IP Library Assignment 067778/0626
Patent Assignment
Reel/Frame 067778/0626

Change of Name

Recorded: 2024-06-18 Pages: 3
Assignor
ALIOS BIOPHARMA, INC.
Executed: 2018-08-30
Assignee
JANSSEN BIOPHARMA, INC.
260 E. GRAND AVENUE, 2ND FLOOR, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property (1)
Substituted Nucleosides, Nucleotides and Analogs Thereof
Application: 17/836,763 →
Publication: US 2023/0167151
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 18, 2024
From: BEIGELMAN, LEONID; WANG, GUANGYI; SMITH, DAVID BERNARD
To: ALIOS BIOPHARMA, INC.
Reel/Frame 067762/0889 →
Assignment of Assignor's Interest Jun 18, 2024
From: JANSSEN PHARMACEUTICA NV
To: JANSSEN PHARMACEUTICALS, INC.
Reel/Frame 067777/0492 →
Change of Name Jun 18, 2024
From: JANSSEN BIOPHARMA, INC.
To: JANSSEN BIOPHARMA, LLC
Reel/Frame 067778/0813 →
Assignment of Assignor's Interest Jun 18, 2024
From: JANSSEN BIOPHARMA, LLC
To: JANSSEN PHARMACEUTICAL NV
Reel/Frame 067780/0232 →
Corrective Assignment to Correct the Applicant Name from Janssen Pharmaceutical Nv to Janssen Pharmaceutica Nv, as Reflected on the Assignment Document Previously Recorded on Reel 67780 Frame 232. Assignor(S) Hereby Confirms the Assignment. Jun 26, 2024
From: JANSSEN BIOPHARMA, LLC
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 067923/0001 →